The Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) leverages world class science to combat HIV globally, in partnership with communities, families, and individuals impacted by the pandemic. Strategies for integrating, promoting, and diffusing HIV detection, prevention, and care are our primary mission. Investigators from UCLA, Friends Research Institute (Friends), LA County, and research and community partners globally collaborate to achieve CHIPTS'mission. CHIPTS creates opportunities for scientific leadership, expertise, and infrastructure to be leveraged to create, understand, and evaluate: 1) structural &community level interventions;2) models of adaptation &adoption of efficacious interventions;3) strategies to reduce disparities for scientists, nations, communities, &individuals;and 4) research agendas that integrate behavioral, biomedical, &technological intervention strategies. The CHIPTS community promotes cutting edge science;networks and builds capacity of scientists, advocates, policy makers, and consumers. Over the next five years, HIV research must capitalize and leverage the revolutionary changes that have occurred: setting the National AIDS Strategy;the global economic recession, which mandates increasingly more cost-effective interventions, especially with a declining USD;technological breakthroughs and integration of mobile phones, point-of-care diagnostics, embedded sensing, the web, and social networking;and the success of circumcision, microbicides, one-minute HIV tests, and oral post- and pre-exposure prophylaxis. To quickly mobilize to these shifts, infrastructure resources and senior expertise is organized to build diverse interdisciplinary teams that can produce new science, scientists, and diffuse the results. CHIPTS'agenda is implemented through six cores, each of which implements scientific, networking, and capacity building activities: Administrative, Development, Methods, Policy, Combination Prevention, and Global Capacity Building. The quality and quantity of the scientific progress is evaluated by a Continuous Quality Improvement Model.

Public Health Relevance

Los Angeles has the second highest number of AIDS cases nationally and is one of the most ethnically diverse epidemics, especially among Men-who-have-Sex-with-Men (MSM). CHIPTS partners on designing and implementing a scientific agenda, networking, and building capacity of the scientists, community and government partner agencies, consumers and policy makers. Concurrently, CHIPTS builds networks in Asia, Africa, the Middle East and South America of scientific collaborations for the epidemic.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
3P30MH058107-17S1
Application #
8727733
Study Section
Special Emphasis Panel (ZMH1-ERB-F (05))
Program Officer
Gordon, Christopher M
Project Start
1997-09-30
Project End
2014-01-31
Budget Start
2013-09-06
Budget End
2014-01-31
Support Year
17
Fiscal Year
2013
Total Cost
$96,196
Indirect Cost
$30,711
Name
University of California Los Angeles
Department
Type
Other Domestic Higher Education
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Shin, S S; Chang, A H; Ghosh, J K C et al. (2016) Isoniazid therapy for Mycobacterium tuberculosis infection in HIV clinics, Los Angeles, California. Int J Tuberc Lung Dis 20:961-6
Wynn, Adriane; Ramogola-Masire, Doreen; Gaolebale, Ponatshego et al. (2016) Acceptability and Feasibility of Sexually Transmitted Infection Testing and Treatment among Pregnant Women in Gaborone, Botswana, 2015. Biomed Res Int 2016:1251238
Perez-Brumer, Amaya G; Oldenburg, Catherine E; Segura, Eddy R et al. (2016) Anonymous partnerships among MSM and transgender women (TW) recently diagnosed with HIV and other STIs in Lima, Peru: an individual-level and dyad-level analysis. Sex Transm Infect :
Roberts, Chelsea P; Klausner, Jeffrey D (2016) Global challenges in human immunodeficiency virus and syphilis coinfection among men who have sex with men. Expert Rev Anti Infect Ther 14:1037-1046
Okafor, Chukwuemeka N; Cook, Robert L; Chen, Xinguang et al. (2016) Trajectories of Marijuana Use among HIV-seropositive and HIV-seronegative MSM in the Multicenter AIDS Cohort Study (MACS), 1984-2013. AIDS Behav :
Tomlinson, Mark; Rotheram-Borus, Mary Jane; le Roux, Ingrid M et al. (2016) Thirty-Six-Month Outcomes of a Generalist Paraprofessional Perinatal Home Visiting Intervention in South Africa on Maternal Health and Child Health and Development. Prev Sci 17:937-948
Pines, Heather A; Gorbach, Pamina M; Weiss, Robert E et al. (2016) Individual-Level, Partnership-Level, and Sexual Event-Level Predictors of Condom Use During Receptive Anal Intercourse Among HIV-Negative Men Who Have Sex with Men in Los Angeles. AIDS Behav 20:1315-26
Herbst de Cortina, Sasha; Bristow, Claire C; Joseph Davey, Dvora et al. (2016) A Systematic Review of Point of Care Testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis. Infect Dis Obstet Gynecol 2016:4386127
Tsai, Alexander C; Tomlinson, Mark; Comulada, W Scott et al. (2016) Intimate Partner Violence and Depression Symptom Severity among South African Women during Pregnancy and Postpartum: Population-Based Prospective Cohort Study. PLoS Med 13:e1001943
Diaz, Chanelle M; Segura, Eddy R; Luz, Paula M et al. (2016) Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study. BMC Infect Dis 16:376

Showing the most recent 10 out of 489 publications